Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

被引:5772
作者
Murray, Christopher J. L. [5 ]
Vos, Theo [2 ]
Lozano, Rafael [5 ]
Naghavi, Mohsen [5 ]
Flaxman, Abraham D. [5 ]
Michaud, Catherine [8 ]
Ezzati, Majid [9 ]
Shibuya, Kenji [10 ]
Salomon, Joshua A. [12 ]
Abdalla, Safa
Aboyans, Victor [18 ]
Abraham, Jerry [19 ]
Ackerman, Ilana
Aggarwal, Rakesh [24 ]
Ahn, Stephanie Y. [5 ]
Ali, Mohammed K.
Alvarado, Miriam [5 ]
Anderson, H. Ross [27 ]
Anderson, Laurie M. [6 ]
Andrews, Kathryn G. [5 ]
Atkinson, Charles [5 ]
Baddour, Larry M. [28 ]
Bahalim, Adil N.
Barker-Collo, Suzanne [29 ]
Barrero, Lope H. [30 ]
Bartels, David H. [17 ]
Basanez, Maria-Gloria
Baxter, Amanda [1 ]
Bell, Michelle L. [31 ]
Benjamin, Emelia J.
Bennett, Derrick [33 ,34 ]
Bernabe, Eduardo [35 ]
Bhalla, Kavi [17 ]
Bhandari, Bishal
Bikbov, Boris [39 ]
Bin Abdulhak, Aref [40 ]
Birbeck, Gretchen [41 ]
Black, James A. [42 ]
Blencowe, Hannah [43 ]
Blore, Jed D. [2 ]
Blyth, Fiona
Bolliger, Ian [5 ]
Bonaventure, Audrey [48 ]
Boufous, Soufi Ane
Bourne, Rupert [51 ]
Boussinesq, Michel
Braithwaite, Tasanee [52 ]
Brayne, Carol [53 ]
Bridgett, Lisa
Brooker, Simon [43 ]
机构
[1] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[3] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia
[4] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia
[5] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA
[6] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA
[7] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA
[8] China Med Board, Boston, MA USA
[9] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England
[10] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan
[11] Harvard Univ, Dept Biostat, Boston, MA 02115 USA
[12] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[13] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA
[14] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA
[15] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA
[16] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA
[17] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA
[18] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France
[19] Univ Texas San Antonio, San Antonio, TX USA
[20] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia
[21] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
[22] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia
[23] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia
[24] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India
[25] Emory Univ, Sch Publ Hlth, Atlanta, GA USA
[26] Emory Univ, Sch Med, Atlanta, GA USA
[27] St Georges Univ London, London, England
[28] Mayo Clin, Rochester, MN USA
[29] Univ Auckland, Auckland 1, New Zealand
[30] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia
[31] Yale Univ, New Haven, CT USA
[32] Boston Univ, Sch Med, Boston, MA 02118 USA
[33] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[34] Univ Oxford, Epidemiol Studies Unit, Oxford, England
[35] Kings Coll London, Inst Dent, London WC2R 2LS, England
[36] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England
[37] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
[38] Queen Mary Univ London, Inst Dent, London, England
[39] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia
[40] King Fahad Med City, Riyadh, Saudi Arabia
[41] Michigan State Univ, E Lansing, MI 48824 USA
[42] MRC, Epidemiol Unit, Cambridge, England
[43] London Sch Hyg & Trop Med, London WC1, England
[44] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia
[45] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia
[46] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia
[47] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
[48] INSERM, Paris, France
[49] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[50] Univ New S Wales, Sydney, NSW, Australia
基金
英国惠康基金; 澳大利亚国家健康与医学研究理事会; 英国医学研究理事会; 瑞典研究理事会;
关键词
PUBLIC-HEALTH UTILITY; ECONOMIC COST; RISK-FACTORS; MORTALITY; POPULATION; COUNTRIES; EXPECTANCY; AUSTRALIA; COPD; LOST;
D O I
10.1016/S0140-6736(12)61689-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. Methods We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. Findings Global DALYs remained stable from 1990 (2.503 billion) to 2010 (2.490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. Interpretation Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.
引用
收藏
页码:2197 / 2223
页数:27
相关论文
共 112 条
  • [1] 100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption
    Adair, T.
    Hoy, D.
    Dettrick, Z.
    Lopez, A. D.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (12) : 1699 - 1705
  • [2] Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease
    Ahern, Ryan M.
    Lozano, Rafael
    Naghavi, Mohsen
    Foreman, Kyle
    Gakidou, Emmanuela
    Murray, Christopher J. L.
    [J]. POPULATION HEALTH METRICS, 2011, 9
  • [3] [Anonymous], BURD DIS FIN REP
  • [4] [Anonymous], ESTIMATION NATL BURD
  • [5] [Anonymous], PROJETO CARGA DOENCA
  • [6] [Anonymous], WORLD HLTH REP 2002
  • [7] [Anonymous], HLTH ADULT BRITAIN 1
  • [8] [Anonymous], HIGHL HLTH EST 2005
  • [9] [Anonymous], J HLTH CARE SOC
  • [10] [Anonymous], VIET NAM BURD DIS IN